Comparison · NCT04069156-deaths
Aspirin Arm (Modified Intent-to-treat Population) vs Placebo Arm (Modified Intent-to-treat Population): deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Aspirin Arm (Modified Intent-to-treat Population) vs Placebo Arm (Modified Intent-to-treat Population): deaths from any cause. Trial comparisons, record NCT04069156-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04069156-deaths
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0751 | 0.0501 | 0.111 | wilson | |
| Risk in group 2 | 0.0709 | 0.0469 | 0.106 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00414 | -0.0389 | 0.0474 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.06 | 0.595 | 1.88 | log | |
| Odds ratio, group 1 over group 2 | 1.06 | 0.571 | 1.98 | log | |
| Number needed to harm, for one more death from any cause on Aspirin Arm (Modified Intent-to-treat Population) than on Placebo Arm (Modified Intent-to-treat Population) | 242 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Aspirin Arm (Modified Intent-to-treat Population) | Patients randomized to the aspirin arm were given aspirin medication (100mg/day). | 22 | 293 | EG001 |
| Group 2 | Placebo Arm (Modified Intent-to-treat Population) | Patients randomized to the placebo arm were given placebo medication. | 21 | 296 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, all-cause mortality
- Time frame
- All adverse events occurring through study completion (median follow up of 14 months) were collected.
Source ClinicalTrials.gov
Trial
- Title
- The ARIES HeartMate 3 Pump IDE Study
- NCT number
- NCT04069156
- Phases
- NA
- Conditions
- Heart Failure
- Interventions
- LVAD Implant, Aspirin 100mg, Placebo oral tablet
- Lead sponsor
- Abbott Medical Devices
- Results first posted
- 2025-03-27
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04069156?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04069156-deaths